The below is from Jan 2016
"When reconstructing a valve with CardioCel, studies showed post-implant remodelling establishing a ‘native’ functioning heart valve. This offers superior hemodynamics and removes the need for life-long anticoagulation".
I assume they have further proof of this claim.
Cheers
Result Presented Next Week, page-18
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |